Meet Former Navy JAG Officer Taking on RINO Thom Tillis in the 2026 North Carolina Senate Race

Senate GOP incumbents brace for MAGA primary challengers

Several GOP Senate incumbents are already staring down the threat of primary challenges next year as friction builds between the MAGA and establishment wings.

Sen. John Cornyn (R-Texas), who plans to run for reelection in 2026, is facing a possible primary challenger in Texas Attorney General Ken Paxton, a longtime ally of President-elect Trump. Meanwhile, Sen. Bill Cassidy (R-La.), who voted to convict Trump in his 2021 impeachment, has already drawn a MAGA challenger. Sen. Thom Tillis (R-N.C.), who was censured by his state party in 2023, could also face a tough fight from the right.   PLEASE CLICK ON THE ABOVE LINK TO READ THE ENTIRE ARTICLE

Rand Paul’s Report Details $1 Trillion in Gov’t Waste. Here Are the Worst Offenders.

Thanks to 

Can They Really Reinvent Kamala Harris in 70 Days?

Harris is not so much a flip-flopper as a padder, who supports anything, without any worry about framing each new position by renouncing her original and opposite one.

By Victor Davis Hanson

September 2, 2024

An Opportunistic Mediocrity

In theory, it should be hard for Kamala Harris to win the presidency of the United States.

Under pressure, Harris just completed her first “live interview”—a disastrous performance that was mysteriously taped, edited, and emotionally supported by her co-interviewed running mate. During the interview, she claimed that her values remain the same even though her manifestations of them have admittedly changed. Translated, that means for the next 70 days, she will advocate for popular policies antithetical to her own values, which will inevitably resurface after the election once the current façade fades away.

She is a Berkelyite who, as attorney general of California, had a proud far-left tenure. The lifelong large corpus of Harris’s left-wing enthusiasm and causes are only now being unearthed. But they are singular in that her riffs of embracing wokism, being a radical, erasing ICE, doing away with private health insurance, or being the last person in the room when Joe Biden made his disastrous decisions were all given to sympathetic media or pandered to crowds.

As a result, she often doubled down. Her emphatic statements were intended to stun audiences. Unlike other leftists, she really was a proud woke, radical and wanted everyone else to be one as well—broadcasting her leftism as openly as she is now cloaking it.

In one respected survey, Harris’s voting record was rated as the most left-leaning in the United States Senate. If she voted to the left of the admitted hardcore socialist Bernie Sanders, what exactly does that make her?

Otherwise, Harris was undistinguished, and often overtly so, as she was exposed as inane in Senate hearings. Her envisioned 2019-2020 primary bid proved an utter disaster. When liberal Democrat voters nationwide were first made aware of her radical record, her left-wing agendas, and her weird wash/rinse/spin word-salad chats, they ran.

(more…)

WASHINGTON — Seventy-two senators and 302 members of the House of Representatives cashed a check from the pharmaceutical industry ahead of the 2020 election — representing more than two-thirds of Congress, according to a new STAT analysis of records for the full election cycle.

Pfizer’s political action committee alone contributed to 228 lawmakers. Amgen’s PAC donated to 218, meaning that each company helped to fund the campaigns of nearly half the lawmakers on Capitol Hill. Overall, the sector donated $14 million.

The breadth of the spending highlights the drug industry’s continued clout in Washington. Even after years of criticism from Congress and the White House over high prices, it remains routine for the elected officials who regulate the health care industry to accept six-figure sums.

The findings, published in a new STAT examination of the drug industry’s political giving, also come on the heels of an extraordinary year for the pharmaceutical industry. In 2020, the federal government leaned heavily on drug makers to develop Covid-19 vaccines at lightning speed — helping to rehabilitate the industry’s reputation and political credibility in the process.

STAT’s analysis includes an interactive map that allows readers to visualize contributions between individual drug industry PACs and states, lawmakers, and congressional districts. It builds upon a previous analysis STAT published before the election, and now includes complete records for the 2020 election cycle.

Donations from companies like Pfizer and Amgen are among the most visibly widespread.

Pfizer, which played arguably the biggest role in 2020’s vaccine race, also had a frenzied year politically. In addition to giving roughly $1 million to members of Congress,  Pfizer also wrote checks to 1,048 individual candidates in state legislative races.

(more…)

June 4, 2024 9:00 pm ET

WASHINGTON—When President Biden met with congressional leaders in the West Wing in January to negotiate a Ukraine funding deal, he spoke so softly at times that some participants struggled to hear him, according to five people familiar with the meeting. He read from notes to make obvious points, paused for extended periods and sometimes closed his eyes for so long that some in the room wondered whether he had tuned out.

In a February one-on-one chat in the Oval Office with House Speaker Mike Johnson, the president said a recent policy change by his administration that jeopardizes some big energy projects was just a study, according to six people told at the time about what Johnson said had happened. Johnson worried the president’s memory had slipped about the details of his own policy.